Comparing Tamsulosin and Solifenacin for Relieving Double J Stent Symptoms: Using the USSQ.

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 13, 2024

Primary Completion Date

December 30, 2024

Study Completion Date

March 30, 2025

Conditions

Ureteral Stent-Related SymptomAlpha BlockerAnticholinergicsUreter Calculi

Interventions

DRUG

Tamsulosin

Tamsulosin 0.4 mg once daily for 14 days

DRUG

solifenacin

Solifenacin 5 mg once daily for 14 day

Trial Locations (1)

Liaquat National Hospital, Karachi, Pakistan, Karachi

All Listed Sponsors

lead

Liaquat National Hospital & Medical College

OTHER

NCT07114848 - Comparing Tamsulosin and Solifenacin for Relieving Double J Stent Symptoms: Using the USSQ. | Biotech Hunter | Biotech Hunter